|
|
|
|
- 130+ participants
- In excess of 75 individual organisations represented
- 33 hours of presentations
- Over 10 hours of networking
- 91% of our attendees ranked the congress as good or excellent
- 30 different countries
› Benefits of sponsoring
|
Conference:
Pre-conference workshop
23 Feb 9am - 5pm
Day 1
24 Feb 8.30am - 6:00pm
Day 2
25 Feb 8.30am - 5:30pm
Post-conference workshop
26 Feb 9am - 5pm
Venue:
The Royal Horseguards Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
|
 Dr Eric Mittleberg,
Vice President Product Development Sandoz In January 2009, Eric Mittleberg assumed the role of Vice President, Product Development for Sandoz US Inc. He reports operationally to Christine Mundkur, President and CEO, Sandoz US Inc. and Head, Commercial Operations, North America, and functionally to Gerhard Schaefer, Head of Global Product Development.
Prior to joining Sandoz, Inc. Eric was with Par Pharmaceuticals in Woodcliff Lake, NJ, where he was Executive Vice President of Pharmaceutical Research & Development. Prior to this, he held the position of Vice President, Scientific Affairs with IVAX Pharmaceuticals in Miami. Through his career, he has also been with Hoffman LaRoche, Key Pharmaceuticals, Schering-Plough and Johnson & Johnson. Eric holds a Bachelors degree in Pharmacy, a Masters in Industrial Pharmacy and a Ph.D. in Pharmaceutics, from St. Johns University College of Pharmacy and Allied Health Professions in New York.Appearing: Day two - Thurs 25 Feb 2010 4pm Role of R&D in generic medicines’ lifecycle management• Definition of “lifecycle management of a generic product”
• Planning the program
• Timing of the program
• Lifecycle management of innovator products as compared to generics
• Review examples of the lifecycle scenario of generic products. Expectations from different possible generic marketing situations, (ie. first to files, commodities, specialty products)
• Development of lifecycle management strategies to answer the needs or challenges of the “natural” lifecycle of a generic product
Dr Eric Mittleberg, Vice President Product Development,
Sandoz |
|
|
|
|
Robert Wessman
Executive Chairman
Alvogen
Petra Danielsohn-Weil
European President, Established Brands
Pfizer
Satish Reddy
Chief Operating Officer & Managing Director
Dr Reddy's Laboratories
Gerard van Odijk
President & Chief Executive Officer
Teva Pharmaceuticals Europe
Honorable Henry A Waxman
Member of Congress
United States of Americas
|
|
|
|
|
|
|
|
|
|
